CLNN
CLNN
NASDAQ · Biotechnology

Clene Inc

$7.28
-0.11 (-1.49%)
As of May 16, 2:20 AM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +159.1% upside
Low Target $15.04
Average Target $18.86
High Target $28.67
Current Price $7.28
Current
$7.28
Target
$18.86
$15.04 $18.86 avg $28.67
Scenario Analysis
Bear Case
$15.04
106.6%
Low target
Base Case
$18.86
+159.1%
Avg target
Bull Case
$28.67
+293.8%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$13.50
-46.1% from high
52-Week Low
$2.28
+219.3% from low
Target vs 52W High
$18.86
+39.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%